1. Home
  2. BELFA vs CLDX Comparison

BELFA vs CLDX Comparison

Compare BELFA & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bel Fuse Inc.

BELFA

Bel Fuse Inc.

N/A

Current Price

$155.54

Market Cap

2.9B

Sector

N/A

ML Signal

N/A

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

N/A

Current Price

$27.51

Market Cap

3.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BELFA
CLDX
Founded
1949
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.0B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
BELFA
CLDX
Price
$155.54
$27.51
Analyst Decision
Buy
Strong Buy
Analyst Count
2
15
Target Price
★ $352.50
$63.79
AVG Volume (30 Days)
73.3K
★ 723.2K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 0.14%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $491,611,000.00
$12,743,000.00
Revenue This Year
$24.35
N/A
Revenue Next Year
$12.99
$410.81
P/E Ratio
$40.02
★ N/A
Revenue Growth
N/A
★ 87.78
52 Week Low
$118.58
$22.33
52 Week High
$293.51
$45.14

Technical Indicators

Market Signals
Indicator
BELFA
CLDX
Relative Strength Index (RSI) 38.70 38.81
Support Level N/A $22.46
Resistance Level $211.83 $31.80
Average True Range (ATR) 10.52 1.52
MACD -0.63 -0.09
Stochastic Oscillator 8.55 15.98

Price Performance

Historical Comparison
BELFA
CLDX

About BELFA Bel Fuse Inc.

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Share on Social Networks: